Overview
Announcements

Ordinary Adjustment | Solactive G2 Healthcare 50 Select Index | Effective Date 25th September 2025

Solactive G2 Healthcare 50 Select Index:

In the ordinary adjustment, the following composition will be implemented effective open 25th September 2025:

3SBIO INC
ABBOTT LABORATORIES
ABBVIE INC
AKESO INC
AMGEN INC
ASCENTAGE PHARMA GROUP INTERNATIONAL
BEIGENE LTD
BOSTON SCIENTIFIC CORP
BRISTOL-MYERS SQUIBB CO
CHINA MEDICAL SYSTEM HOLDINGS LTD
CHINA RESOURCES PHARMACEUTICAL
CSPC PHARMACEUTICAL GROUP LTD
DANAHER CORP
DUALITYBIO-B ORD
ELEVANCE HEALTH INC
ELI LILLY & CO
EVEREST MEDICINES LTD
GENSCRIPT BIOTECH CORP
GILEAD SCIENCES INC
GRAND PHARMACEUTICAL GROUP LTD
HANSOH PHARMACEUTICAL GROUP CO
HCA HEALTHCARE INC
HENGRUI PHARMA ORD H
HUTCHMED CHINA LTD
INNOCARE PHARMA LTD
INNOVENT BIOLOGICS INC
INTUITIVE SURGICAL INC
JOHNSON & JOHNSON
KEYMED BIOSCIENCES INC
MEDTRONIC PLC
MERCK & CO. INC.
MICROPORT SCIENTIFIC CORP
PFIZER INC
QUANTUMPHARM INC
REMEGEN CO LTD-H
SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD
SHANGHAI MICROPORT MEDBOT GR
SIMCERE PHARMACEUTICAL GROUP
SINO BIOPHARMACEUTICAL LTD ORD
SKB BIO-B ORD H
STRYKER CORP
THERMO FISHER SCIENTIFIC INC
UNITED LABORATORIES INTERNATIONAL HOLDINGS LTD.
UNITEDHEALTH GROUP INC
VERTEX PHARMACEUTICALS INC
WUXI APPTEC CO LTD
WUXI BIOLOGICS CAYMAN INC
ZAI LAB LTD
ZOETIS INC